title: An interview with Fernanda Laezza, MD, PhD, by Vicki Glaser.
authors.forename: Fernanda
authors.initials: F
authors.lastname: Laezza
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001369:Axons / Q000502:physiology; D053447:Channelopathies / Q000188:drug therapy; D055808:Drug Discovery; D055724:Electrophysiological Phenomena; D006801:Humans; D009474:Neurons / Q000502:physiology; D011506:Proteins / Q000737:chemistry / Q000502:physiology; D026941:Sodium Channel Blockers / Q000494:pharmacology; D015222:Sodium Channels / Q000187:drug effects / Q000235:genetics / Q000502:physiology*
chemical_list: D011506:Proteins; D026941:Sodium Channel Blockers; D015222:Sodium Channels